Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | APC |
Variant | P1443fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | APC P1443fs results in a change in the amino acid sequence of the Apc protein beginning at aa 1443 of 2843, likely resulting in premature truncation of the functional protein (UniProt.org). P1443fs has not been characterized, however, due to the effects of other truncation mutations downstream of P1443 (PMID: 18199528, PMID: 10346819), is predicted to lead to a loss of Apc protein function. |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC inact mut APC P1443fs |
Transcript | NM_000038.6 |
gDNA | chr5:g.(112839920_112839921) |
cDNA | c.(4327_4326) |
Protein | p.P1443fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000038 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001127510.2 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_000038.5 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354905.1 | chr5:g.(112840400_112840401) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354895.1 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407450.1 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001127510.3 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354897.2 | chr5:g.(112839890_112839891) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407455.1 | chr5:g.(112840169_112840170) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407456.1 | chr5:g.(112840169_112840170) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354897.1 | chr5:g.(112839890_112839891) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001127510 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354895.2 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_000038.6 | chr5:g.(112839920_112839921) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407454.1 | chr5:g.(112840169_112840170) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407452.1 | chr5:g.(112839950_112839951) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001407457.1 | chr5:g.(112840169_112840170) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
NM_001354905.2 | chr5:g.(112840400_112840401) | c.(4327_4326) | p.P1443fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|